Pro CLB Global opened at ₹46.08, in line with its previous close of ₹46.08. In the last trading session on 12 Nov 2026, the stock traded between ₹46.00 and ₹48.00, with an average traded price of ₹47.79. It showed an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Pro CLB Global is now worth
₹ 69,565.00
Giving a profit of
₹ 59,565.00 (595.65%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+1.92 (+4.17%)
Day High
₹48.00
Day Low
₹46.00
Day Open
₹46.08
Prev Close
₹46.08
Volume
11,113
Value Traded
₹0.05 Cr
1W Return
2.13%
1M Return
5.26%
3M Return
45.45%
6M Return
39.13%
1Y Return
6.79%
Market Cap (₹ Cr.)
24
PE Ratio
12.20
PB Ratio
1.02
Dividend Yield
-
ROE
7.65%
ROCE
7.65%
Book Value (₹)
45.31
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
2.13%
6 Weeks
-
1 Month
5.26%
3 Months
45.45%
9 Months
13.69%
No data available.
Pro CLB Global board approves Q2FY27 standalone financial results
Pro CLB Global board approved standalone unaudited results for Q2FY27 and H1FY27. Board meeting held on November 2, 2026, from 6:00 pm to 7:00 pm in Ahmedabad. Approval covers period ended September 30, 2026, per SEBI LODR Regulation 33.
10 days agoPro CLB Global appoints Het Kalpeshkumar Shah as CEO
Het Kalpeshkumar Shah appointed CEO effective October 14, 2026. Shah continues as Director while taking on CEO role. Succession follows Monil Navinchandra Vora's resignation same day. Shah brings finance and accounting background to leadership team.
29 days agoPro CLB Global passes all resolutions at 32nd AGM with 99.99% votes
All five resolutions passed with 99.99% votes in favor. 95 shareholders voted, representing 13.54% of paid-up capital. Satish Papnai regularized as Independent Director via special resolution. New statutory and secretarial auditors appointed for multi-year terms.
1mo agoPro CLB Global approves ₹34.9 crore warrant allotment to 130 investors
Pro CLB Global allotted 1,09,20,255 convertible warrants to 130 non-promoter investors. Issue price set at ₹31.96 per warrant with ₹7.99 collected upfront as 25% payment. Mideast Healthcare Pvt Ltd received the largest single allotment of 700,000 warrants. Ten applicants were rejected due to failure to pay the initial 25% consideration. Warrants are exercisable for equity shares within 18 months or they will lapse.
1mo agoPro CLB Global schedules 32nd AGM for September 30, 2026
Pro CLB Global schedules its 32nd AGM for September 30, 2026. Shareholders will adopt audited financials for FY26 ended March 31. M/s. Shweta Jain & Co LLP appointed as Statutory Auditors for five years. E-voting period runs from September 27 to September 29, 2026.
2mo agoPro CLB Global shareholders approve capital hike and warrant issuance
Shareholders approved four special resolutions including capital hike and warrant issuance. Voting participation was 12.22% of total paid-up capital as on July 24, 2026. All resolutions passed with 99.99% support from 6,23,632 shares voted. Board authorized to borrow funds and make investments beyond statutory limits.
2mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹354.40 | -1.31% | ₹27,706.09 | 17.80 | +20.22% | |
| ₹288.35 | +0.23% | ₹20,097.73 | 28.10 | -21.29% | |
| ₹440.45 | +2.81% | ₹19,034.47 | 27.80 | +27.43% | |
| ₹1,558.70 | +0.60% | ₹14,659.69 | 20.10 | -30.53% | |
| ₹190.44 | -0.98% | ₹13,597.42 | 20.50 | +23.61% | |
| ₹690.60 | +0.47% | ₹9,590.38 | 96.30 | +12.74% | |
| ₹56.15 | +4.68% | ₹8,422.50 | 26.70 | -15.67% | |
| ₹1,067.70 | -0.39% | ₹7,523.01 | 18.80 | -15.95% | |
| ₹31.01 | -0.55% | ₹7,232.17 | 12.90 | +0.00% | |
| ₹151.25 | +1.34% | ₹6,927.84 | 63.50 | +24.74% | |
| ₹613.95 | -0.96% | ₹6,392.13 | 93.50 | +51.97% | |
| ₹519.90 | -0.21% | ₹5,946.67 | 105.40 | -11.11% |
An investment of ₹10,000 made 5 years ago in Pro CLB Global is now worth
₹ 69,565.00
Giving a profit of
₹ 59,565.00 (595.65%)
Note: Past profits do not guarantee future returns.
